|
PAIS
Paracetamol (Acetaminophen) In Stroke
Ongoing trial
 |
Author(s) |
van Breda EJ, van der Worp HB, van Gemert HMA, Algra A, Kappelle LJ, van Gijn J, Koudstaal PJ, Dippel DWJ, and PAIS investigators |
 |
Title(s) |
PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN 74418480] |
|
Reference(s) |
BMC Cardiovasc Disord 2005;5:24 |
|
Disease |
Stroke |
|
Purpose |
To examine the effects of early antipyretic therapy on the risk of death or dependency in patients with acute stroke |
|
Study design |
Randomised, double-blind, placebo-controlled |
|
Follow-up |
Aim 3 months |
|
Patients |
Aim 2500 patients, aged > 18 years, with acute ischaemic stroke or primary intracerebral haemorrhage and body temperature 36.0–39.0oC |
|
Treatment regimen |
Paracetamol, 1000 mg 6 times/day, or placebo for 3 days |
|
Results |
Not yet available |
|
|
|
